An Interest In:
Web News this Week
- April 20, 2024
- April 19, 2024
- April 18, 2024
- April 17, 2024
- April 16, 2024
- April 15, 2024
- April 14, 2024
Some of Our Sources
- Slashdot
- BoingBoing
- Techcrunch
- Six Revisions
- Fuel Your Creativity
- Noupe
- 24 Ways
- Specky Boy
- Willems Lab
- TechPowerUp
Help Webnuz
Referal links:
April 17, 2016 08:00 pm
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/Tn_yDWC6874/some-tumors-are-responding-to-a-new-cancer-therapy
Some Tumors Are Responding to A New Cancer Therapy
A new cancer therapy in an early-stage trial by the U.S. National Cancer Institute "continued to be safe and show durable responses against solid tumors for some patients," reports Bloomberg. "In a trial of 14 patients who received different doses, three patients' cancers have shrunk partially, according to a study presented Sunday... The researchers had presented initial positive data in November, and the updated study shows that the three partial responses were durable, with one cervical cancer patient's response continuing at 15 months." Kite Pharma Inc. licensed the therapy, and by the end of the year will file an "investigational new drug" application with the FDA to begin the next round of testing. The therapy involves genetically engineered T cells, targeted to the solid tumors using the MAGE-A3 protein as a unique marker expressed in up to 30 percent of cancers.Read more of this story at Slashdot.
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/Tn_yDWC6874/some-tumors-are-responding-to-a-new-cancer-therapy
Share this article:
Tweet
View Full Article
Slashdot
Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..More About this Source Visit Slashdot